Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumanirole in early Parkinson's disease
NCT00058838Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of sumanirole in Parkinson's disease (PD), sponsored by Pfizer. Started Apr 2003; status: completed.
02
Drugs
sumanirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00058838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058838.